These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23927405)

  • 1. Erbium laser for the treatment of disseminated superficial actinic porokeratosis: a case report.
    Rosenblum J; Roenigk HH
    Dermatol Surg; 2013 Oct; 39(10):1543-5. PubMed ID: 23927405
    [No Abstract]   [Full Text] [Related]  

  • 2. [Squamous cell carcinoma and disseminated superficial actinic porokeratosis].
    Rémond B; Dompmartin A; Mandard JC; Leroy D
    Ann Dermatol Venereol; 1994; 121(1):50-2. PubMed ID: 8092731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 segmental manifestation of disseminated superficial porokeratosis showing a systematized pattern of involvement and pronounced cancer proneness.
    Murata Y; Kumano K; Takai T
    Eur J Dermatol; 2001; 11(3):191-4. PubMed ID: 11358722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porokeratotic eccrine ostial and dermal duct nevus treated with a combination erbium/CO2 laser: a case and brief review.
    Wong JW; Summers EM; Taylor MB; Harris RM
    Dermatol Online J; 2011 Sep; 17(9):10. PubMed ID: 21971275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of disseminated superficial actinic porokeratosis with Q-switched ruby laser.
    Itoh M; Nakagawa H
    J Dermatol; 2007 Dec; 34(12):816-20. PubMed ID: 18078407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squamous cell carcinoma arising from giant porokeratosis.
    Ma DL; Vano-Galvan S
    Dermatol Surg; 2009 Dec; 35(12):1999-2000. PubMed ID: 19732108
    [No Abstract]   [Full Text] [Related]  

  • 7. Light and laser treatment modalities for disseminated superficial actinic porokeratosis: a systematic review.
    Aird GA; Sitenga JL; Nguyen AH; Vaudreuil A; Huerter CJ
    Lasers Med Sci; 2017 May; 32(4):945-952. PubMed ID: 28239750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant Porokeratosis With Malignant Transformation to Squamous Cell Carcinoma.
    Vence L; Thompson CB; Callen JP; Brown TS
    Dermatol Surg; 2018 Apr; 44(4):580-581. PubMed ID: 29293104
    [No Abstract]   [Full Text] [Related]  

  • 9. Case of disseminated superficial actinic porokeratosis successfully treated with Q-switched ruby laser.
    Kubo N; Asahina A; Kamide R; Itoh M
    J Dermatol; 2021 May; 48(5):e244-e245. PubMed ID: 33745188
    [No Abstract]   [Full Text] [Related]  

  • 10. Systematized linear porokeratosis: concept of type 2 segmental manifestation implies an increased cancer risk.
    Schwarz N; Stadie V; Kreft B; Happle R; Marsch WCh; Fiedler E
    J Dermatol; 2012 Nov; 39(11):953-4. PubMed ID: 22779423
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of classic porokeratosis of Mibelli with Q-switched ruby laser.
    Liu Y; Wang Y; Nie X; Yan L; Liu Y; Zhou J; Tong W; Tao J
    Eur J Dermatol; 2012; 22(1):125-6. PubMed ID: 22062326
    [No Abstract]   [Full Text] [Related]  

  • 12. Unusual evolution of giant porokeratosis developing in two renal transplant patients.
    Pérez-Crespo M; Betlloch I; Lucas-Costa A; Bañuls-Roca J; Niveiro de Jaime M; Mataix J
    Int J Dermatol; 2008 Jul; 47(7):759-60. PubMed ID: 18613889
    [No Abstract]   [Full Text] [Related]  

  • 13. Coexistence of linear porokeratosis and disseminated superficial actinic porokeratosis: a type 2 segmental manifestation.
    Suárez-Amor O; Pereiro-Ferreirós M; Ginarte M; Peteiro C; Toribio J
    Acta Derm Venereol; 2007; 87(4):363-4. PubMed ID: 17598043
    [No Abstract]   [Full Text] [Related]  

  • 14. Giant porokeratosis.
    Bozdağ KE; Biçakçi H; Ermete M
    Int J Dermatol; 2004 Jul; 43(7):518-20. PubMed ID: 15230892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal squamous cell carcinoma arising from transplant-associated porokeratosis.
    Silver SG; Crawford RI
    J Am Acad Dermatol; 2003 Nov; 49(5):931-3. PubMed ID: 14576684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentric Bowen disease in linear porokeratosis.
    Guenova E; Hoetzenecker W; Metzler G; Röcken M; Schaller M
    Eur J Dermatol; 2007; 17(5):439-40. PubMed ID: 17673390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linear porokeratosis superimposed on disseminated superficial actinic porokeratosis: report of two cases exemplifying the concept of type 2 segmental manifestation of autosomal dominant skin disorders.
    Freyschmidt-Paul P; Hoffmann R; König A; Happle R
    J Am Acad Dermatol; 1999 Oct; 41(4):644-7. PubMed ID: 10495390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated superficial actinic porokeratosis improved with fractional 1927-nm laser treatments.
    Ross NA; Rosenbaum LE; Saedi N; Arndt KA; Dover JS
    J Cosmet Laser Ther; 2016; 18(1):53-5. PubMed ID: 26820042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma arising from lesions of porokeratosis palmaris et plantaris disseminata.
    Seishima M; Izumi T; Oyama Z; Maeda M
    Eur J Dermatol; 2000 Aug; 10(6):478-80. PubMed ID: 10980475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verrucous Porokeratosis treated with 2940 nm Erbium:YAG laser.
    Aşkın Ö; Özkoca D; Uzunçakmak TK; Kutlubay Z
    Dermatol Ther; 2022 Apr; 35(4):e15342. PubMed ID: 35094481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.